Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
PRGO Perrigo Company plc daily Stock Chart
PRGO [NYSE]
Perrigo Company plc
Healthcare | Drug Related Products | Ireland
financial highlights | statements
IndexS&P 500 P/E57.42 EPS (ttm)0.96 Insider Own0.10% Shs Outstand139.48M Perf Week-5.37%
Market Cap7.72B Forward P/E11.75 EPS next Y4.71 Insider Trans35.42% Shs Float135.69M Perf Month-12.85%
Income137.80M PEG11.48 EPS next Q1.00 Inst Own91.10% Short Float5.26% Perf Quarter-24.17%
Sales4.82B P/S1.60 EPS this Y103.40% Inst Trans5.41% Short Ratio4.99 Perf Half Y-26.82%
Book/sh41.19 P/B1.34 EPS next Y3.56% ROA1.10% Target Price74.67 Perf Year-36.01%
Cash/sh3.20 P/C17.29 EPS next 5Y5.00% ROE2.10% 52W Range55.51 - 95.93 Perf YTD-36.50%
Dividend0.76 P/FCF16.03 EPS past 5Y-27.40% ROI3.30% 52W High-42.30% Beta0.61
Dividend %1.37% Quick Ratio1.30 Sales past 5Y6.90% Gross Margin39.40% 52W Low-0.29% ATR2.17
Employees10400 Current Ratio1.90 Sales Q/Q-8.00% Oper. Margin6.00% RSI (14)26.06 Volatility3.01% 2.93%
OptionableYes Debt/Eq0.58 EPS Q/Q-256.40% Profit Margin2.50% Rel Volume0.79 Prev Close56.38
ShortableYes LT Debt/Eq0.54 EarningsNov 08 BMO Payout84.80% Avg Volume1.43M Price55.35
Recom2.80 SMA20-9.25% SMA50-16.64% SMA200-25.46% Volume1,131,450 Change-1.83%
Nov-13-18Downgrade Berenberg Buy → Hold
Aug-10-18Reiterated Stifel Hold $92 → $87
Jul-30-18Downgrade Argus Buy → Hold
Jul-12-18Downgrade Goldman Neutral → Sell
Jan-03-18Initiated Leerink Partners Mkt Perform $90
Dec-08-17Upgrade Argus Hold → Buy
Nov-10-17Upgrade RBC Capital Mkts Underperform → Sector Perform $64 → $86
Oct-05-17Reiterated UBS Buy $84 → $98
Sep-07-17Initiated Oppenheimer Outperform $88
Aug-11-17Upgrade Goldman Sell → Neutral
Aug-11-17Reiterated RBC Capital Mkts Underperform $60 → $64
Jun-16-17Initiated Cantor Fitzgerald Overweight $85
Jun-05-17Downgrade RBC Capital Mkts Sector Perform → Underperform $66 → $60
Mar-03-17Reiterated B. Riley & Co. Neutral $83 → $67
Feb-28-17Reiterated Canaccord Genuity Buy $100 → $97
Feb-22-17Initiated Canaccord Genuity Buy $100
Jan-23-17Reiterated Jefferies Hold $84 → $70
Jan-17-17Reiterated RBC Capital Mkts Sector Perform $92 → $85
Nov-11-16Upgrade BofA/Merrill Underperform → Neutral
Nov-11-16Reiterated B. Riley & Co. Neutral $87 → $97
Dec-14-18 09:57PM  Hedge Funds Are Selling Perrigo Company plc (PRGO) Insider Monkey
Dec-10-18 08:52AM  Perrigo Announces the Launch of an AB Rated Generic Version of Topicort® Topical Spray 0.25% PR Newswire
Dec-08-18 09:30AM  Perrigo (PRGO) Down 4.7% Since Last Earnings Report: Can It Rebound? Zacks
Dec-06-18 04:18PM  Edited Transcript of PRGO earnings conference call or presentation 8-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
07:20AM  Market Trends Toward New Normal in Perrigo Company plc, Sina, Gerdau S.A, Sinclair Broadcast Group, Invesco, and Enbridge Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Dec-04-18 04:05PM  Sol-Gel Technologies Announces Sixth Agreement for a Generic Product Candidate with Perrigo GlobeNewswire
Nov-28-18 08:46AM  Perrigo Announces Patent Litigation Settlement For The Generic Version Of Sernivo® Spray, 0.05% PR Newswire
Nov-27-18 08:26AM  Perrigo Launches Its AB Rated Generic Version of Solaraze® Gel 3% PR Newswire
Nov-26-18 09:01AM  Perrigo Announces Tentative FDA Approval For The First To File Generic Version Of Ultravate® Lotion 0.05% PR Newswire
Nov-23-18 05:19AM  New Strong Sell Stocks for November 23rd Zacks
Nov-16-18 04:20PM  David Einhorn's Top 4 Sells in 3rd Quarter GuruFocus.com
Nov-13-18 04:05PM  Sol-Gel Technologies Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-12-18 10:41AM  Weekly CEO Buys Highlight GuruFocus.com
Nov-11-18 10:51AM  Stocks That Fell to 3-Year Lows in the Week of Nov. 9 GuruFocus.com
Nov-09-18 03:15PM  Perrigo Co Plc (PRGO) CEO Murray S Kessler Bought $1 million of Shares GuruFocus.com
06:55AM  Todays Research Reports on Stocks to Watch: Perrigo Company and Novelion Therapeutics ACCESSWIRE
Nov-08-18 05:05PM  The Biggest Loser: Perrigo Tumbles 16% Barrons.com -16.32%
04:20PM  3 Stocks Move Thursday GuruFocus.com
01:13PM  US STOCKS-S&P 500 edges lower ahead of Fed decision Reuters
01:05PM  Perrigo Company PLC (PRGO) Q3 2018 Earnings Conference Call Transcript Motley Fool
12:43PM  Midday Movers: Perrigo Plunges, TripAdvisor Soars, Tesla Advances Barrons.com
11:53AM  US STOCKS-Weak results keep S&P, Nasdaq lower ahead of Fed decision Reuters
11:51AM  [$$] Perrigo Strikes Out Again The Wall Street Journal
10:32AM  Do Directors Own Perrigo Company plc (NYSE:PRGO) Shares? Simply Wall St.
10:27AM  Perrigo (PRGO) Beats on Q3 Earnings, Cuts View, Shares Down Zacks
10:16AM  US STOCKS-Wall St dips as weak earnings dampen surge from midterm elections Reuters
08:55AM  US STOCKS-Wall St set to open lower after election surge; Fed meet in focus Reuters
08:35AM  Perrigo (PRGO) Q3 Earnings Beat Estimates Zacks
08:20AM  Stocks making the biggest move premarket: ARRS, COMM, PRGO, DHI, PRTY & more CNBC
08:00AM  10 Health Care Stocks Seen Jumping on Takeovers Investopedia
07:29AM  Perrigo: 3Q Earnings Snapshot Associated Press
06:00AM  Perrigo Company plc Reports Third Quarter 2018 Financial Results PR Newswire
Nov-07-18 01:31PM  Perrigo Q3 Earnings Preview Benzinga
Nov-06-18 11:17AM  What's in the Cards for Perrigo (PRGO) This Earnings Season? Zacks
Oct-31-18 11:32AM  Perrigo Announces Quarterly Dividend PR Newswire
Oct-29-18 09:10AM  Perrigo Confirms Patent Challenge For Generic Version Of Kerydin® PR Newswire
Oct-26-18 08:30AM  Recent Analysis Shows Eco-Stim Energy Solutions, Pan American Silver, Innospec, Camping World, RLJ Lodging Trust, and Perrigo Company plc Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Oct-25-18 09:19AM  Perrigo To Release Third Quarter Calendar Year 2018 Financial Results On November 8, 2018 PR Newswire
Oct-20-18 03:43AM  Edited Transcript of PRGO earnings conference call or presentation 9-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Oct-17-18 12:48PM  What You Must Know About Perrigo Company plcs (NYSE:PRGO) Financial Strength Simply Wall St.
Oct-15-18 08:56AM  Perrigo Announces The Launch Of An AB Rated Generic Version Of Androgel® Topical Gel, 1.62% PR Newswire
Oct-09-18 11:30AM  [$$] The Future at Perrigo Is Brighter Than Investors Think The Wall Street Journal
10:27AM  Perrigo (PRGO) Hires Consumer Products Veteran as New CEO Zacks
09:16AM  [$$] Stocks to Watch: Alphabet, Exxon, Papa John's, Tesla The Wall Street Journal
06:44AM  Perrigo replaces CEO Roehrhoff with consumer goods veteran Reuters
06:37AM  Perrigo replaces CEO Roehrhoff with consumer goods veteran Reuters
Oct-08-18 09:41PM  [$$] Drugmaker Perrigo Hires a New CEO The Wall Street Journal
06:23PM  Perrigo replaces CEO Rohrhoff with consumer goods veteran Reuters
06:07PM  Perrigo Taps Tobacco Executive as CEO in Shift From Drugs Bloomberg
06:07PM  Perrigo replaces CEO Rohrhoff with consumer goods veteran Reuters
05:17PM  Perrigo appoints Murray Kessler as CEO MarketWatch
05:02PM  Perrigo Appoints Murray S. Kessler As President And Chief Executive Officer In Line With Shift To Consumer-Focused Strategy PR Newswire
Oct-01-18 10:24AM  Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10% PR Newswire
Sep-28-18 09:00AM  Perrigo Announces Patent Litigation Settlement for the Generic Version of Picato® Gel PR Newswire
Sep-27-18 08:20AM  Analysis: Positioning to Benefit within Enerplus, ExlService, Gilead Sciences, 51job, QUALCOMM, and Perrigo Company plc Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Sep-19-18 09:00AM  Haeggquist & Eck, LLP is Investigating Claims Against Perrigos Directors and Officers for Breach of Fiduciary Duty Concerning Revenue Recognition for MS Pharmaceutical Tysabri Business Wire
Sep-17-18 10:38AM  Investors Are Undervaluing Perrigo Company plc (NYSE:PRGO) By 28.77% Simply Wall St.
Sep-10-18 09:36AM  Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod Zacks
Sep-07-18 09:05AM  Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Imodium® Multi-Symptom Relief PR Newswire
Aug-29-18 04:15PM  Perrigo to Reschedule Investor Event PR Newswire
Aug-22-18 02:25PM  Perrigo Company plc (NYSE:PRGO): Can It Deliver A Superior ROE To The Industry? Simply Wall St.
Aug-21-18 08:00AM  Today's Research Reports on Trending Tickers: Mallinckrodt and Perrigo Company ACCESSWIRE
Aug-20-18 08:00AM  Today's Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Perrigo Company ACCESSWIRE
Aug-10-18 11:11AM  Perrigo Needs 'Meet-Or-Beat' Quarters, Deutsche Bank Says In Downgrade Benzinga
Aug-09-18 07:46PM  [$$] Perrigo to Separate Its Prescription Pharmaceutical Business The Wall Street Journal -10.56%
05:57PM  Perrigo Company plc -- Moody's says Perrigo's ratings unaffected following announced separation of prescription business Moody's
05:06PM  [$$] Perrigo to Separate Its Prescription Pharmaceutical Business The Wall Street Journal
02:46PM  Mylan, Perrigo Earnings: Look Out Below! Barrons.com
02:08PM  Generic Drugmakers Struggle Despite U.S. Push for Copycats Bloomberg
10:35AM  Perrigo plans to separate prescription pharma business Reuters
09:48AM  Perrigo (PRGO) Beats on Q2 Earnings, Cuts View, Shares Down Zacks
08:48AM  Perrigo stock drops 6.5% after Q2 revenue miss, guidance cuts; company plans to separate drug unit MarketWatch
07:54AM  Stocks making the biggest moves premarket: VIAB, TRCO, BKNG, PRTY & more CNBC
07:30AM  Perrigo (PRGO) Beats Q2 Earnings Estimates Zacks
06:30AM  Perrigo Co. Plc to Host Earnings Call ACCESSWIRE
05:02AM  Perrigo: 2Q Earnings Snapshot Associated Press
12:11AM  Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex® PR Newswire
12:07AM  Perrigo Announces Plan To Separate Prescription Pharmaceuticals Business PR Newswire
12:02AM  Perrigo Company plc Reports Second Quarter 2018 Financial Results PR Newswire
Aug-08-18 03:05PM  Perrigo's Q2 Earnings Preview Benzinga
09:18AM  Drug/Biotech Stock Q2 Earnings on Aug 9: PRGO, BDSI & More Zacks
08:41AM  What's in the Cards for Perrigo (PRGO) This Earnings Season? Zacks
Aug-01-18 08:44AM  Perrigo Announces Quarterly Dividend PR Newswire
Jul-26-18 08:23AM  Perrigo To Release Second Quarter Calendar Year 2018 Financial Results On August 9, 2018 PR Newswire
Jul-24-18 07:35AM  Complimentary Technical Snapshots on Aquinox Pharma and Three More Healthcare Stocks ACCESSWIRE
Jul-17-18 05:12PM  After the Bell: Dow Rises 56 Points as Stocks Keep Chugging Higher Barrons.com
Jul-12-18 03:21PM  Drug Makers Can't Cure Investor Impatience Barrons.com
10:28AM  Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings Benzinga
Jun-29-18 09:37PM  AbbVie, AndroGel partner owe $448 million in antitrust case -U.S. judge Reuters
Jun-25-18 11:07AM  Conviction of SAC's Martoma upheld despite jury instructions Reuters
Jun-22-18 01:52PM  Should You Buy Perrigo Company plc (NYSE:PRGO) Based On These Aspects? Simply Wall St.
Jun-08-18 01:19PM  Valeant Pharmaceuticals Intl Inc Has New Name But Same Problems InvestorPlace
Jun-06-18 11:41AM  Valeant & Perrigo: Buy One, Skip the Other Barrons.com
07:55AM  Report: Developing Opportunities within Silicon Motion Technology, Green Brick Partners, Alliance Resource Partners, Perrigo Company plc, Epizyme, and Landec Future Expectations, Projections Moving into 2018 GlobeNewswire
Jun-01-18 02:23PM  Perrigo Stock Is Just Bearish, Any Way You Look At It TheStreet.com
07:30AM  Breakfast Technical Briefing on Johnson & Johnson and Three Other Additional Healthcare Stocks ACCESSWIRE
May-30-18 08:30AM  Perrigo to Present at the Jefferies 2018 Healthcare Conference PR Newswire
May-24-18 08:35AM  Perrigo Confirms Patent Challenge For Generic Version Of Sernivo® Spray, 0.05% PR Newswire
May-21-18 01:42PM  Starboard Value Buys $30.2 Million More in Perrigo Stock Barrons.com
May-20-18 04:21PM  Benzinga's Insider Buys Of The Week: JPMorgan, Philip Morris And More Benzinga
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc has a collaborative agreement with the Sol-Gel Technologies Ltd. for the development, manufacturing, and commercialization of an ivermectin cream in the United States. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COHEN GARY MDirectorNov 14Option Exercise39.623,053120,96020,317Nov 15 10:35 AM
Samuels Theodore R. IIDirectorNov 13Buy65.403,500228,9027,618Nov 14 09:47 AM
Parker Geoffrey M.DirectorNov 12Buy65.353,000196,0585,500Nov 13 06:15 AM
Andersen SvendEVP & President CHCINov 09Buy63.013,900245,7397,200Nov 09 01:56 PM
KINGMA TODD WExecutive VP, General CounselNov 09Buy63.993,200204,76823,587Nov 09 01:53 PM
KESSLER MURRAY SCEONov 09Buy63.7915,6831,000,37315,683Nov 09 01:51 PM
Andersen SvendEVP & President CHCIAug 14Buy69.437,200499,8967,200Aug 16 03:30 PM
Winowiecki RonaldCFOJul 23Option Exercise75.972,297174,5036,320Jul 24 01:36 PM
Weninger PaulEVP, Quality OperationsJun 29Option Exercise72.9173253,3704,486Jul 03 07:51 PM
Quinn GrainneEVP, Chief Medical OfficerJun 29Option Exercise72.9126219,1022,533Jul 03 07:49 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainJun 29Option Exercise72.9182760,2972,562Jul 03 07:38 PM
Winowiecki RonaldCFOJun 29Option Exercise72.9181859,6404,257Jul 03 07:34 PM
Wesolowski JohnEVP, President RxJun 29Option Exercise72.9148135,0702,113Jul 03 07:30 PM
Samuels Theodore R. IIDirectorJun 06Option Exercise73.224,265312,2835,624Jun 08 05:22 PM
KINDLER JEFFREY BDirectorJun 06Option Exercise73.224,265312,2834,793Jun 08 05:20 PM
Parker Geoffrey M.DirectorJun 06Option Exercise73.224,265312,2835,277Jun 08 05:19 PM
Alford Bradley ADirectorJun 06Option Exercise73.224,265312,2834,796Jun 08 05:17 PM
CLASSON ROLF ADirectorJun 06Option Exercise73.224,265312,2834,265Jun 08 05:14 PM
Smith Jeffrey CDirectorJun 06Option Exercise73.224,265312,2834,793Jun 08 05:12 PM
BRLAS LAURIEDirectorJun 06Option Exercise73.225,331390,33617,888Jun 08 05:10 PM
COHEN GARY MDirectorJun 06Option Exercise73.224,265312,28319,312Jun 08 05:09 PM
Karaboutis AdrianaDirectorJun 06Option Exercise73.224,265312,2834,265Jun 08 05:08 PM
O'Connor DonalDirectorJun 06Option Exercise73.224,265312,2837,443Jun 08 05:05 PM
Smith Jeffrey CDirectorMay 17Buy75.8950,0003,794,6453,662,220May 17 09:03 PM
Smith Jeffrey CDirectorMay 16Buy75.83100,0007,582,6103,616,273May 17 09:03 PM
Smith Jeffrey CDirectorMay 15Buy75.21250,00018,802,0133,526,419May 17 09:03 PM
Roehrhoff UweCEOMar 05Buy81.857,500613,8637,500Mar 07 04:46 PM
Winowiecki RonaldInterim CFOMar 01Option Exercise79.571,776141,3163,957Mar 05 03:17 PM
Wesolowski JohnEVP, President RxMar 01Option Exercise79.571,03382,1961,963Mar 05 03:12 PM
KINGMA TODD WExecutive VP, General CounselDec 28Option Exercise87.272,571224,37119,565Dec 29 11:45 AM
KINGMA TODD WExecutive VP, General CounselDec 28Sale88.521,500132,78017,252Dec 29 11:45 AM
Winowiecki RonaldInterim CFODec 22Option Exercise87.0184673,6102,449Dec 27 04:35 PM
open in yahoo | open in reuters | open in google